Post a Job

Featured Jobs

Distribution-Loan Specialist

Daybright Financial
(Remote)

Daybright Financial logo

Client Relationship Manager (401k)

Prime Benefits
(Remote / Baltimore MD)

Prime Benefits logo

Actuarial Services Consultant

July Business Services LLC
(Remote)

July Business Services LLC logo

Senior Retirement Plan Administrator

Daybright Financial
(Remote)

Daybright Financial logo

Retirement Plan Documents Specialist

Loren D. Stark Company
(Remote / Houston TX)

Loren D. Stark Company logo

Senior Retirement Plan Administrator

PlanPerfect, Inc.
(Remote)

PlanPerfect, Inc. logo

Sr. Plan Consultant

BPAS
(Remote / Hybrid)

BPAS logo

Plan Consultant II

MAP Retirement
(Remote / Jacksonville FL)

MAP Retirement logo

Product Counsel, ERISA & Operations

Human Interest
(Remote)

Human Interest logo

View More Employee Benefits Jobs

Free Publications

LinkedIn icon     Twitter icon     Facebook icon

GLP-1 Indications Continue to Expand: Potential Approvals Expected Through 2026
Lockton Link to more items from this source
Aug. 27, 2025

"Wegovy has now received FDA approval for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate-to-advanced fibrosis.... The growing GLP-1 approval pipeline has significant implications for employers in terms of cost, coverage, and employee access. Throughout the end of 2026, new indications across a broad range of clinical applications are expected that employers should be aware of[.]"  MORE >>

Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title).
An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above).